Markets:

Overview

News

Currencies

International

Treasuries

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

169.38 +1.83 (+1.09%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

54 Biggest Movers From Yesterday ↗

April 20, 2022

Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 19, 2022

Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) stock increased by 331.9% to $10.41 during Tuesday's regular session. Trading volume for Checkmate Pharmaceuticals'...

Via Benzinga

Earnings Scheduled For March 1, 2022 ↗

March 01, 2022

Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...

Via Benzinga

Dow Up Over 400 Points as Wall Street Pores Over Earnings ↗

April 19, 2022

Stocks are pointed higher this afternoon, as Wall Street pores over the latest batch of quarterly reports amid one of the busiest weeks of earnings season.

Via Talk Markets

Hydrogen Stocks News: Why Are PLUG, FCEL, BE Stocks Up Today? ↗

April 19, 2022

Hydrogen stocks are in the news Tuesday as several companies see their shares head higher today thanks to a massive deal.

Via InvestorPlace

38 Stocks Moving In Tuesday's Mid-Day Session ↗

April 19, 2022

Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) climbed 329.2% to $10.43 after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to acquire the company for $...

Via Benzinga

Why Is Axsome Therapeutics (AXSM) Stock Up Today? ↗

April 19, 2022

Axsome Therapeutics (AXSM) stock is on the rise Tuesday as the company edges closer to its first drug approval from the FDA.

Via InvestorPlace

Axsome Therapeutics Stock Rockets As Its First FDA Approval Looks Imminent ↗

April 19, 2022

The company agreed to the FDA's post-marketing requirements for a depression drug.

Via Investor's Business Daily

Axsome Therapeutics Stock Is Surging: Here's Why ↗

April 19, 2022

Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher Tuesday after the company announced it received and agreed to Postmarketing Requirements/Commitments proposed...

Via Benzinga

Benzinga's Daily Brief On Trending Tickers For April 19, 2022: Plug Power, Twitter, Cassava Sciences And More ↗

April 19, 2022

Benzinga’s “Daily Brief On Trending Tickers” features top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 19, 2022

Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) shares increased by 331.5% to $10.4 during Tuesday's pre-market session. The market value of their outstanding shares...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates ↗

April 01, 2022

Biopharma stocks are sensitive to a key binary event called the PDUFA date, the date by which the Food and Drug Administration is required to give its verdict on a regulatory application filed with...

Via Benzinga

Peering Into Axsome Therapeutics Inc's Recent Short Interest ↗

March 30, 2022

Axsome Therapeutics Inc's (NASDAQ:AXSM) short percent of float has risen 15.16% since its last report. The company recently reported that it has 4.42 million shares sold short,...

Via Benzinga

Why Axsome Therapeutics Stock Is Trading Higher ↗

March 28, 2022

Axsome Therapeutics Inc (NASDAQ: AXSM) is trading higher Monday morning after the company announced it will acquire Sunosi from Jazz Therapeutics PLC (NASDAQ: JAZZ).

Via Benzinga

Axsome Acquires Sleep Disorder Drug From Jazz Pharma, Expanding Its Neuroscience Portfolio ↗

March 28, 2022

Axsome Therapeutics Inc (NASDAQ: AXSM) has

Via Benzinga

Best Biotech Stocks To Buy In 2022 ↗

March 15, 2022

Biotechnology is the study of living creatures, biological systems, or derivatives to develop or improve healthcare products and therapies. This technology is connected with medical and...

Via Talk Markets

Axsome Therapeutics: Q4 Earnings Insights ↗

March 01, 2022

Axsome Therapeutics (NASDAQ:AXSM) reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar ↗

February 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 07, 2022

Gainers Agile Therapeutics (NASDAQ:AGRX) ...

Via Benzinga

Stock Wars: Axsome Therapeutics Vs. Global Blood Therapeutics ↗

February 02, 2022

Benzinga’s weekly Stock Wars matches up two leaders in a major industry sector with the goal of determining which company is the better investment.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 07, 2022

Gainers ContraFect (NASDAQ:CFRX) stock mo...

Via Benzinga

2 Top Biotech Stocks Ready for a Bull Run ↗

November 24, 2021

Both of these companies have potential catalysts on the way.

Via The Motley Fool

Axsome Therapeutics, inc (AXSM) Q3 2021 Earnings Call Transcript ↗

November 08, 2021

AXSM earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Why Axsome Therapeutics Stock Is Rising Today ↗

November 08, 2021

The company provided its third-quarter update.

Via The Motley Fool

2 Biotech Stocks Poised for Jaw-Dropping Growth ↗

October 17, 2021

These two tiny drugmakers could make early shareholders wealthy.

Via The Motley Fool

Topics Stocks

Why Axsome Therapeutics Stock Rocketed Higher This Week ↗

October 15, 2021

Optimism among investors is growing for the possible approval of the biotech's MDD drug.

Via The Motley Fool

1 Beaten-Down Stock With 10X Potential ↗

October 14, 2021

This biotech is down, but it isn't out just yet.

Via The Motley Fool

45 Biggest Movers From Yesterday ↗

October 13, 2021

Gainers ESSTech Inc (NYSE: GWH) shares surged 128.4% to close at $23.80 onTuesday. ESS Inc, the Bill Gates-backed battery maker went public on the NewYork Stock Exchange on...

Via Benzinga

Why Axsome Therapeutics Stock Caught Fire in September ↗

October 06, 2021

This beaten-down biotech regained some lost ground last month.

Via The Motley Fool

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shareholder Notice: Investigation over Possible Wrongdoing ↗

September 29, 2021

San Diego, CA -- (SBWIRE) -- 09/29/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Axsome Therapeutics, Inc.

Via SBWire

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

All News about Axsome Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today